The Prognostic Value of FGFR3 Expression in Patients with T1 Non-Muscle Invasive Bladder Cancer.

Danijel SikicHelge TaubertJohannes BreyerMarkus EcksteinVeronika WeyererBastian KeckJennifer KubonWolfgang OttoThomas S WorstMaximilian C KriegmairPhilipp ErbenArndt HartmannBernd WullichRalph M WirtzSven Wach

Published in: Cancer management and research (2021)

Stage T1 NMIBC patients with high FGFR3 expression show shorter RFS but better OS than patients with low FGFR3 expression.

Keyphrases

poor prognosis
muscle invasive bladder cancer
binding protein
long non coding rna